ArticleOrthopedic reviews2026
Advances in Arthroscopic Superior Capsular Reconstruction of the Shoulder: A Narrative Review.
Article in Orthopedic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Irreparable massive rotator cuff tear (IMRCT) is a significant challenge in shoulder surgery, with traditional treatments yielding suboptimal outcomes. Superior Capsular Reconstruction (SCR), an innovative arthroscopic joint-preserving procedure, provides a new solution for IMRCT by restoring superior glenohumeral joint stability.
methodsThis narrative review systematically searched PubMed, Web of Science, Embase and Cochrane Library for arthroscopic SCR studies using the terms "superior capsular reconstruction", "irreparable massive rotator cuff tear", "arthroscopy" and "graft material". The search covered 2013 (the first SCR report) to 2025. Peer-reviewed English full-text articles were included, and duplicate, low-quality and irrelevant literatures were excluded. Finally, 45 high-quality studies (clinical cohort, biomechanical experiments, systematic reviews) were selected to analyze SCR advances in indications, graft selection, surgical techniques and rehabilitation.
resultsSCR effectively improves shoulder function, alleviates pain and increases acromiohumeral distance (AHD) in IMRCT patients without severe glenohumeral arthritis. Tensor fascia lata autograft has the best long-term survival but donor-site morbidity risk; acellular dermal matrix allograft avoids donor-site injury but has high cost and slow integration; long head of the biceps tendon autograft is ideal for small-to-medium tears due to minimal invasiveness and cost-effectiveness. Hamstring and peroneus longus tendon grafts have specific clinical applications.
conclusionSCR is an effective IMRCT treatment, with individualized graft selection based on patient conditions, cost-effectiveness and regional availability being critical. Future research should establish SCR technical standards, evaluate long-term outcomes, refine patient selection and explore biologic augmentation and 3D-engineered grafts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.